Comprehensive Genomic Assessment of Advanced-Stage GI Stromal Tumors Using the Japanese National Center for Cancer Genomics and Advanced Therapeutics Database We analyzed the genomic and immune ...

Plasma protein profiling may offer a more refined diagnostic tool for classifying mastocytosis subtypes and predicting disease course. The study emphasizes that mastocytosis is not solely driven by ...

The protein homeostasis (proteostasis) network (Balch et al, 2008), consisting of a collection of molecular chaperones, ...

Nomic Bio Inc. (Nomic), a proteomics company with the highest-throughput platform for multiplexed protein quantification, and the Parker Institute for Cancer Immunotherapy (PICI), a collaborative ...

Higher activity of PGC-1α enables brown fat cells in females to achieve thermogenic activity and energy expenditure compared ...

Utilizing data from The Cancer Genome Atlas (TCGA) via Cbioportal, gene expression profiles of 8,132 breast cancer patients from 23 studies were analysed. 2030 patients were categorized into 1,743 ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported new results from Study 9001-103. Also known as ...

Co announces that it has extended its collaboration agreement with the Medical University of South Carolina. In partnership with Lumera scientists, M.U.S.C researchers intend to develop an antibody ...

To enhance CAR T therapies, scientists are actively studying TCR signaling and T-cell exhaustion mechanisms to improve CAR T persistence and function. Additionally, there is a growing trend towards ...

In the post-genomic era, long non-coding RNAs (lncRNAs) have emerged as critical regulators in various cancers and hold ...